Overexpression of the Mesenchymal Stem Cell Cxcr4 Gene in Irradiated Mice Increases the Homing Capacity of These Cells

Cell Biochemistry and Biophysics

Volumn 67, Issue 3, 2013, Pages 1181-1191

  Chen, Wei ^a   Li, Miao ^b   Cheng, Hai ^a   Yan, Zhiling ^a   Cao, Jiang ^a   Pan, Bin ^a   Sang, Wei ^a   Wu, Qingyun ^a   Zeng, Lingyu ^a   Li, Zhenyu ^a   Xu, Kailin ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b Hospital of Xuzhou   (China)

Author keywords

Chemokine receptor 4; Lentivirus; Mesenchymal stem cell; Mice; Stromal cell derived factor 1; Total body irradiation

Indexed keywords

ANIMALIA; LENTIVIRUS; MURINAE; MUS;

CHEMOKINE RECEPTOR CXCR4; CXCL12 PROTEIN, MOUSE; CXCR4 PROTEIN, MOUSE; CYTOKINE; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; STROMAL CELL DERIVED FACTOR 1;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CELL MOTION; CYTOLOGY; GENE EXPRESSION; GENE VECTOR; GENETICS; LENTIVIRINAE; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; CHEMOKINE CXCL12; CYTOKINES; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LENTIVIRUS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, CXCR4; WHOLE-BODY IRRADIATION;

EID: 84888323877     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9632-6     Document Type: Article

References (28)

1. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147.
2. Parekkadan, B., & Milwid, J. M. (2010). Mesenchymal stem cells as therapeutics. Annual Review of Biomedical Engineering, 12, 87-117.
3. English, K., French, A., & Wood, K. J. (2010). Mesenchymal stromal cells: Facilitators of successful transplantation? Cell Stem Cell, 7, 431-442.
4. Wagner, J., Kean, T., Young, R., Dennis, J. E., & Caplan, A. I. (2009). Optimizing mesenchymal stem cell-based therapeutics. Current Opinion in Biotechnology, 20, 531-536.
5. Barbash, I. M., Chouraqui, P., Baron, J., Feinberg, M. S., Etzion, S., Tessone, A., et al. (2003). Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body distribution. Circulation, 108, 863-868.
6. Lee, R. H., Pulin, A. A., Seo, M. J., Kota, D. J., Ylostalo, J., Larson, B. L., et al. (2009). Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell, 5, 54-63.
7. Gao, J., Dennis, J. E., Muzic, R. F., Lundberg, M., & Caplan, A. I. (2001). The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs, 169, 12-20.
8. Karp, J. M., & Leng Teo, G. S. (2009). Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell, 4, 206-216.
9. Nombela-Arrieta, C., Ritz, J., & Silberstein, L. E. (2011). The elusive nature and function of mesenchymal stem cells. Nature Reviews Molecular Cell Biology, 12, 126-131.
10. Lapidot, T., Dar, A., & Kollet, O. (2005). How do stem cells find their way home? Blood, 106, 1901-1910.
11. Wynn, R. F., Hart, C. A., Corradi-Perini, C., O'Neill, L., Evans, C. A., Wraith, J. E., et al. (2004). A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood, 104, 2643-2645.
12. Honczarenko, M., Le, Y., Swierkowski, M., Ghiran, I., Glodek, A. M., & Silberstein, L. E. (2006). Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells, 24, 1030-1041.
13. Son, B. R., Marquez-Curtis, L. A., Kucia, M., Wysoczynski, M., Turner, A. R., Ratajczak, J., et al. (2006). Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells, 24, 1254-1264.
14. Ponte, A. L., Marais, E., Gallay, N., Langonne, A., Delorme, B., Herault, O., et al. (2007). The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells, 25, 1737-1745.
15. Rombouts, W. J., & Ploemacher, R. E. (2003). Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia, 17, 160-170.
16. Mazzinghi, B., Ronconi, E., Lazzeri, E., Sagrinati, C., Ballerini, L., Angelotti, M. L., et al. (2008). Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. Journal of Experimental Medicine, 205, 479-490.
17. Kyriakou, C., Rabin, N., Pizzey, A., Nathwani, A., & Yong, K. (2008). Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica, 93, 1457-1465.
18. Cheng, Z., Ou, L., Zhou, X., Li, F., Jia, X., Zhang, Y., et al. (2008). Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Molecular Therapy, 16, 571-579.
19. Cho, S. W., Sun, H. J., Yang, J. Y., Jung, J. Y., An, J. H., Cho, H. Y., et al. (2009). Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4 prevents bone loss in ovariectomized mice. Molecular Therapy, 17, 1979-1987.
20. Ricks, D. M., Kutner, R., Zhang, X. Y., Welsh, D. A., & Reiser, J. (2008). Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev, 17, 441-450.
21. Bobis-Wozowicz, S., Miekus, K., Wybieralska, E., Jarocha, D., Zawisz, A., Madeja, Z., et al. (2011). Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice. Experimental Hematology, 39(686-696), e684.
22. Zhang, D., Fan, G. C., Zhou, X., Zhao, T., Pasha, Z., Xu, M., et al. (2008). Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium. Journal of Molecular and Cellular Cardiology, 44, 281-292.
23. Dar, A., Goichberg, P., Shinder, V., Kalinkovich, A., Kollet, O., Netzer, N., et al. (2005). Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nature Immunology, 6, 1038-1046.
24. Kollet, O., Shivtiel, S., Chen, Y. Q., Suriawinata, J., Thung, S. N., Dabeva, M. D., et al. (2003). HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. Journal of Clinical Investigation, 112, 160-169.
25. Shi, M., Li, J., Liao, L., Chen, B., Li, B., Chen, L., et al. (2007). Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: Role in homing efficiency in NOD/SCID mice. Haematologica, 92, 897-904.
26. Liu, H., Liu, S., Li, Y., Wang, X., Xue, W., Ge, G., et al. (2012). The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury. PLoS One, 7, e34608.
27. Gheisari, Y., Azadmanesh, K., Ahmadbeigi, N., Nassiri, S. M., Golestaneh, A. F., Naderi, M., et al. (2012). Genetic modification of mesenchymal stem cells to overexpress CXCR4 and CXCR7 does not improve the homing and therapeutic potentials of these cells in experimental acute kidney injury. Stem Cells Dev, 21(6), 2969-2980.
28. Xun, C. Q., Thompson, J. S., Jennings, C. D., Brown, S. A., & Widmer, M. B. (1994). Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood, 83, 2360-2367.